Delivery Order SPE2DB24D3013-SPE2DB25FFPST
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,399.82 for TALTZ 80 MG/ML AutoInjector on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,753.04 to AmerisourceBergen Drug Corp on June 4, 2025, for TALTZ 80 mg/ml autoinjector units. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award of this pharmaceutical product through the federal procurement process. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 5, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of TALTZ 80 mg/ml auto-injectors, with a ceiling value of $12,872.48 and an ultimate completion date of June 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,287.82 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 3, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $15,104.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on May 16, 2025, with an ultimate completion date of May 19, 2025. This contract is a non-set-aside award and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic...
- The Defense Logistics Agency awarded a delivery order valued at $25,456.25 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication commonly used to treat autoimmune...
- The Defense Logistics Agency awarded a $47,612.95 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) units. This is a firm fixed-price contract with an ultimate completion date of September 5, 2025, and represents a competitively awarded, non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $24,342.24 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) units, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $6,665.40 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order represents a non-competitive procurement under an existing contract vehicle. TALTZ (ixekizumab) is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis and rheumatoid arthritis. The performance will take place at...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFPSTDelivery Order
The Defense Logistics Agency awarded a $21,972.38 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TALTZ 80 mg/mL autoinjectors. This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat autoimmune conditions including psoriasis and rheumatoid arthritis. This delivery order fulfills the Defense Health Agency's pharmaceutical supply requirements as part of DLA's comprehensive global pharmaceutical support program for military healthcare systems. AmerisourceBergen's extensive portfolio of federal medical procurement contracts demonstrates its established capability to meet defense health system needs across multiple therapeutic domains, supporting military personnel, veterans, and other government healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.0k | 8/22/25 |